Repeat Endoscopic Ultrasound-Guided Fine-Needle Aspiration in Patients with Suspected Pancreatic Cancer: Diagnostic Yield and Associated Change in Access to Appropriate Care

Table 1

Cytopathological class of first and second EUS-FNA in patients who underwent repeat EUS-FNA for diagnosis of suspected pancreatic malignancy at St. Paul’s Hospital, Vancouver, British Columbia, between 2007 and 2014.

	Cytopathological class	Second EUS-FNA							Total
		Indeterminate (I)	Negative (II)	Atypical (III)	Likely (IV)	Diagnostic (V)	NET	Lymphoma
First EUS-FNA	Indeterminate (I)	5	8	6	1	2	0	0	22
	Negative (II)	0	5	0	0	0	0	0	5
	Atypical (III)	1	3	2	2	2	1	1	12
	Likely (IV)	1	0	0	0	3	0	0	4
	Diagnostic (V)	0	0	0	0	0	0	0	0
	NET	0	0	0	0	0	1	0	1
	Lymphoma	0	0	0	0	0	1	0	1
	Total	7	16	8	3	7	3	1	45

Comparison of first and second EUS-FNA results in patients with suspected pancreatic cancer. Divided by cytopathological diagnosis (EUS-FNA: endoscopic ultrasound fine-needle aspiration; NET: neuroendocrine tumor).